John Paulson’s portfolio: Paulson & Co 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026

Q3 2016 filing in brief

In its Q3 2016 13F, filed November 14, 2016, Paulson & Co reported $9.2B across 94 US positions. The largest: SHIRE PLC-ADR (9.8%), ALLERGAN PLC (9.7%), MYLAN NV (9.0%), TEVA (8.0%), GLD (6.5%). In the quarter it opened 22 positions, sold out of 14, added to 16 and trimmed 29; positions opened and sold out came to 12.5% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 14, 2016

  • 22 New
  • 16 Added
  • 29 Trimmed
  • 14 Exited

94 positions at September 30, 2016. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1—SHIRE PLC-ADR$905M4.7M9.81%−10.1%Trimmed
2—ALLERGAN PLC$896M3.9M9.71%−1.5%Trimmed
3—MYLAN NV$831M21.8M9.01%−1.0%Held
4TEVATEVA PHARMACEUTICAL-SP ADR$740M16.1M8.02%−4.2%Trimmed
5GLDSPDR GOLD TRUST$600M4.8M6.50%0.0%Held
6—MALLINCKRODT PLC$556M8.0M6.03%−4.7%Trimmed
7AIGAMERICAN INTERNATIONAL GROUP$538M9.1M5.83%0.0%Held
8STAYUSDEXTENDED STAY AMERICA INC$535M37.7M5.80%−11.7%Trimmed
9—VALEANT PHARMACEUTICALS INTE$463M18.9M5.02%−1.1%Trimmed
10AKRXEURAKORN INC$245M9.0M2.65%−0.4%Held
11AU3EURANGLOGOLD ASHANTI-SPON ADR$203M12.8M2.21%−0.3%Held
12—CAESARS ACQUISITION CO-CL A$163M13.1M1.77%−0.2%Held
13—ENDO INTERNATIONAL PLC$160M8.0M1.74%−11.2%Trimmed
14NGNOVAGOLD RESOURCES INC$143M25.6M1.55%−0.4%Held
15VMWEURVMWARE INC-CLASS A$140M1.9M1.52%−2.9%Trimmed
16HPEHEWLETT PACKARD ENTERPRIS$136M6.0M1.47%—New
17—SYNERGY PHARMACEUTICALS INC$134M24.2M1.45%−12.7%Trimmed
18—REALOGY HOLDINGS CORP$124M4.8M1.34%0.0%Held
19CZRCAESARS ENTERTAINMENT CORP$107M14.4M1.16%−0.2%Held
20BIIBBIOGEN INC$96M308.0K1.04%+150.2%Added
21CIEI 3.125 05/15/24COBALT INTL ENERGY INC 3.125% 05/15/2024$83M219.2M0.90%0.0%Held
22—AMERICAN CAPITAL LTD$73M4.3M0.79%+2.5%Added
23TSUTIM PARTICIPACOES SA-ADR$70M5.7M0.76%−2.4%Trimmed
24AEMAGNICO EAGLE MINES LTD$68M1.3M0.74%0.0%Held
25WLHUSDWILLIAM LYON HOMES-CL A$62M3.3M0.67%0.0%Held
26OASEUROASIS PETROLEUM INC$60M5.2M0.65%−1.5%Trimmed
27—BANK OF AMERICA CORP-CW19$60M12.9M0.65%−0.4%Held
28ODPEUROFFICE DEPOT INC$55M15.4M0.59%−2.2%Trimmed
29—DELL TECHNOLOGIES INC-CL V$52M1.1M0.57%—New
30—RANDGOLD RESOURCES LTD-ADR$50M500.0K0.54%0.0%Held
31—ALLERGAN PLCcall option$49M214.7K0.54%0.0%Held
32TMUST-MOBILE US INC$45M954.0K0.48%−2.6%Trimmed
33TTWOTAKE-TWO INTERACTIVE SOFTWRE$44M974.2K0.48%−2.6%Trimmed
34ATVIEURACTIVISION BLIZZARD INC$43M974.2K0.47%−2.6%Trimmed
35—TOBIRA THERAPEUTICS INC$43M1.1M0.46%—New
36GRFSGRIFOLS SA-ADR$40M2.5M0.43%−66.3%Trimmed
37—COBALT INTERNATIONAL ENERGY$39M31.2M0.42%−20.1%Trimmed
38VNDAVANDA PHARMACEUTICALS INC$36M2.2M0.39%−43.7%Trimmed
39—MYLAN NVcall option$36M940.4K0.39%−8.7%Trimmed
40—ENZYMOTEC LTD$29M4.2M0.32%−0.4%Held
41ALXNALEXION PHARMACEUTICALS INC$28M227.7K0.30%−15.0%Trimmed
42METAFACEBOOK INC-A$27M212.7K0.30%+47.3%Added
43CIEI 2.625 12/01/19COBALT INTL ENERGY INC 2.625% 12/01/2019$25M48.3M0.27%−50.9%Trimmed
44—STERIS PLC$23M311.8K0.25%—New
45EBAYEBAY INC$21M628.1K0.22%—New
46THMINTERNATIONAL TOWER HILL MINE$21M23.1M0.22%0.0%Held
47—LOXO ONCOLOGY INC$19M736.9K0.21%+194.4%Added
48FDXFEDEX CORP$19M106.8K0.20%+46.7%Added
49ETSYETSY INC$18M1.3M0.19%+2.6%Added
50—LIVANOVA PLC$17M277.1K0.18%+6.6%Added
51SNYSANOFI-ADR$16M417.0K0.17%+5.4%Added
52IAGIAMGOLD CORP$16M3.9M0.17%0.0%Held
53CYHCOMMUNITY HEALTH SYSput option$15M1.3M0.16%+44.9%Added
54HUMHUMANA INC$14M79.5K0.15%—New
55HCAHCA HOLDINGS INC$12M162.5K0.13%—New
56—SYNTHESIS ENERGY SYSTEMS INC$12M10.0M0.13%0.0%Held
57—SHIRE PLC-ADRcall option$12M60.0K0.13%−31.8%Trimmed
58MARMARRIOTT INTERNATIONAL -CL A$11M170.0K0.12%—New
59MCKMCKESSON CORP$11M67.0K0.12%+10.7%Added
60CVSCVS HEALTH CORP$11M122.2K0.12%—New
61BSXBOSTON SCIENTIFIC CORP$10M410.0K0.11%+336.2%Added
62PFEPFIZER INC$9M252.0K0.09%−50.6%Trimmed
63—ST JUDE MEDICAL INC$8M94.5K0.08%+107.7%Added
64EXPEEXPEDIA INC$7M63.3K0.08%−29.0%Trimmed
65—MONSTER WORLDWIDE INC$7M2.0M0.08%—New
66TMQTRILOGY METALS INC$6M11.6M0.07%—New
67—MEAD JOHNSON NUTRITION CO$6M78.5K0.07%—New
68—INFOBLOX INC$6M230.0K0.07%—New
69PBYIPUMA BIOTECHNOLOGY INC$6M84.5K0.06%−42.0%Trimmed
70—INGRAM MICRO INC-CL A$5M145.1K0.06%+7.6%Added
71JNJJOHNSON & JOHNSON$4M35.0K0.04%−72.7%Trimmed
72—ITC HOLDINGS CORP$4M85.1K0.04%+7.0%Added
73—CARMIKE CINEMAS INC$4M120.0K0.04%—New
74MELIMERCADOLIBRE INC$4M20.9K0.04%—New
75DXCMDEXCOM INC$4M43.5K0.04%−64.8%Trimmed
76—KAMADA LTD$4M730.8K0.04%−0.7%Held
77LLYELI LILLY & CO$4M45.8K0.04%—New
78—FELCOR LODGING TRUST INC$3M500.0K0.03%−47.4%Trimmed
79SHOPSHOPIFY INC - CLASS A$3M74.2K0.03%—New
80INSMINSMED INC$3M205.2K0.03%0.0%Held
81RIGLRIGEL PHARMACEUTICALS INC$3M805.0K0.03%−19.5%Trimmed
82TLNDTALEND SA - ADR$3M100.8K0.03%—New
83CBOECBOE HOLDINGS INC$2M38.4K0.03%—New
84ALDR1EURALDER BIOPHARMACEUTICALS INC$2M74.0K0.03%—New
85DVAXDYNAVAX TECHNOLOGIES CORP$2M174.0K0.02%0.0%Held
86—WCI COMMUNITIES INC$2M70.0K0.02%—New
87BCRXBIOCRYST PHARMACEUTICALS INC$2M363.1K0.02%+38.0%Added
88—ESPERION THERAPEUTICS INC$1M102.0K0.02%0.0%Held
89ALNYALNYLAM PHARMACEUTICALS INC$1M19.3K0.01%0.0%Held
90ARDMEURARADIGM CORP$1M146.9K0.01%+122.9%Added
91—BANK OF AMERICA CORP-CW-B$894K8.9M0.01%−0.2%Held
92OSG1EUROVERSEAS SHIPHOLDING GROUP-A$477K45.1K0.01%0.0%Held
93—CELLDEX THERAPEUTICS INC$286K70.8K0.00%0.0%Held
94—LIBERTY GLOBAL PLC LILAC - A$138K5.0K0.00%—New
14 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—STARWOOD HOTELS&RESORTS WRLD$333M4.5M
—E M C CORP MASS$273M10.0M
MTG 2 04/01/20MGIC INVT CORP WIS$127M114.5M
—B/E AEROSPACE INC$45M980.6K
—QUINTILES TRANSNATIO HLDGS$11M164.2K
—CIGNA CORPORATION$8M61.8K
—NOVACOPPER INC$6M11.6M
DWREEURDEMANDWARE INC$5M65.0K
—RITE AID CORP$4M580.9K
—PRICELINE GRP INC$2M1.7K
—ENDO INTL PLCcall option$2M119.9K
—PERRIGO CO PLC$1M12.5K
EGRXEAGLE PHARMACEUTICALS INC$815K21.0K
—K2M GROUP HLDGS INC$737K47.5K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.